The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Dysbiosis of Gram‑negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type�2 diabetic patients with chronic kidney disease
Open accessAbstract
Lipopolysaccharide (LPS), a potent endotoxin present in the outer membrane of Gram-negative bacteria, causes chronic immune responses associated with inflammation. In the present study, the association between LPS and the dysbiosis of Gram-negative bacteria in the gut microbiome was determined in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (T2DM-CKD; stages 4 and 5, not on dialysis) compared with healthy individuals. Microbiome diversity was analyzed in patients with T2DM-CKD and healthy controls by sequencing the hypervariable sub-regions of the 16S ribosomal RNA gene from stool samples. Serum samples were assayed by ELISA for LPS, C-reactive protein (CRP), tumor necrosis factor-α (TNFα), interleukin-6 (IL6) and endothelin-1. A total of four gut Gram-negative phyla (Bacteroidetes, Proteobacteria, Fusobacteria and Verrucomicrobia) were identified in the gut microbiome of the T2DM-CKD and control groups. Proteobacteria, Verrucomicrobia and Fusobacteria exhibited significantly increased relative abundance in patients with T2DM-CKD when compared with controls (P<0.05). The levels of serum LPS were significantly increased in patients with T2DM-CKD compared with controls (P<0.05). Elevated serum LPS was significantly correlated with increased levels of TNFα, IL6 and CRP. The dysbiosis of Gram-negative bacteria in the gut microbiome of patients with T2DM-CKD may contribute to the elevated serum levels of LPS and the consequential effects on the inflammatory biomarkers in these patients. The association between the dysbiosis of Gram-negative bacteria in the gut microbiome of patients with T2DM-CKD, increased LPS levels and the effects on inflammatory biomarkers may provide insight into potential diagnostic and therapeutic approaches in the treatment of T2DM-CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
LPS/TLR4 signal transduction pathway
Lu, Y.-C., Yeh, W.-C., & Ohashi, P. S. (2008) · Cytokine · doi:10.1016/j.cyto.2008.01.006 · Cited by 3,301
The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
Park, B. S., Song, D. H., Kim, H. M., Choi, B.-S., Lee, H., & Lee, J.-O. (2009) · Nature · doi:10.1038/nature07830 · Cited by 2,428
Cani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., Burcelin, R. G., Tuohy, K. M., Gibson, G. R., & Delzenne, N. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0791-0 · Cited by 1,774
Intestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755
Wu, H., Esteve, E., Tremaroli, V., Khan, M. T., Caesar, R., Mannerås-Holm, L., Ståhlman, M., Olsson, L. M., Serino, M., Planas-Fèlix, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4345 · Cited by 1,632
Environmental and Gut Bacteroidetes: The Food Connection
Thomas, F., Hehemann, J.-H., Rebuffet, E., Czjzek, M., & Michel, G. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00093 · Cited by 1,337
Chronic kidney disease alters intestinal microbial flora
Vaziri, N. D., Wong, J., Pahl, M., Piceno, Y. M., Yuan, J., DeSantis, T. Z., Ni, Z., Nguyen, T.-H., & Andersen, G. L. (2013) · Kidney International · doi:10.1038/ki.2012.345 · Cited by 1,164
Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00392 · Cited by 1,110 · cited 1×
“The loss of integrity of intestinal permeability allows the translocation of LPS from the gut into the blood (58-61).”
BackgroundCekanaviciute, E., Yoo, B. B., Runia, T. F., Debelius, J. W., Singh, S., Nelson, C. A., Kanner, R., Bencosme, Y., Lee, Y. K., Hauser, S. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711235114 · Cited by 1,036
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974
Intestinal barrier function in health and gastrointestinal disease
Camilleri, M., Madsen, K., Spiller, R., Van Meerveld, B. G., & Verne, G. N. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01921.x · Cited by 908
Guo, S., Al-Sadi, R., Said, H. M., & Ma, T. Y. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.10.014 · Cited by 719
The contributory role of gut microbiota in cardiovascular disease
Tang, W. H. W., & Hazen, S. L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72331 · Cited by 641
TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis
Kuzmich, N., Sivak, K., Chubarev, V., Porozov, Y., Savateeva-Lyubimova, T., & Peri, F. (2017) · Vaccines · doi:10.3390/vaccines5040034 · Cited by 633
Lipopolysaccharide signaling in endothelial cells
Dauphinee, S. M., & Karsan, A. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700366 · Cited by 614
Ussar, S., Griffin, N. W., Bezy, O., Fujisaka, S., Vienberg, S., Softic, S., Deng, L., Bry, L., Gordon, J. I., & Kahn, C. R. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.007 · Cited by 533
Intestinal barrier: An interface between health and disease
FARHADI, A., BANAN, A., FIELDS, J., & KESHAVARZIAN, A. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03032.x · Cited by 530
Raetz, C. R. H., Ulevitch, R. I., Wright, S. D., Sibley, C. H., Ding, A., & Nathan, C. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.12.1916089 · Cited by 507
SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY
Oberholzer, A., Oberholzer, C., & Moldawer, L. L. (2001) · Shock · doi:10.1097/00024382-200116020-00001 · Cited by 481
Fukui, H., Brauner, B., Bode, J. C., & Bode, C. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90933-3 · Cited by 461
Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2
Tripathi, A., Lammers, K. M., Goldblum, S., Shea-Donohue, T., Netzel-Arnett, S., Buzza, M. S., Antalis, T. M., Vogel, S. N., Zhao, A., Yang, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906773106 · Cited by 443
Gram-positive and gram-negative bacterial toxins in sepsis: A brief review
Ramachandran, G. (2014) · Virulence · doi:10.4161/viru.27024 · Cited by 411
SILVA, RDP, Greengenes, NCBI and OTT — how do these taxonomies compare?
Balvočiūtė, M., & Huson, D. H. (2017) · BMC Genomics · doi:10.1186/s12864-017-3501-4 · Cited by 405
Santoru, M. L., Piras, C., Murgia, A., Palmas, V., Camboni, T., Liggi, S., Ibba, I., Lai, M. A., Orrù, S., Blois, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10034-5 · Cited by 387
Metabolic endotoxemia and diabetes mellitus: A systematic review
Gomes, J. M. G., Costa, J. D. A., & Alfenas, R. D. C. G. (2017) · Metabolism · doi:10.1016/j.metabol.2016.12.009 · Cited by 334
Total Lipopolysaccharide from the Human Gut Microbiome Silences Toll-Like Receptor Signaling
d’Hennezel, E., Abubucker, S., Murphy, L. O., & Cullen, T. W. (2017) · mSystems · doi:10.1128/msystems.00046-17 · Cited by 324
Guerrero-Preston, R., Godoy-Vitorino, F., Jedlicka, A., Rodríguez-Hilario, A., González, H., Bondy, J., Lawson, F., Folawiyo, O., Michailidi, C., Dziedzic, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9710 · Cited by 313
Bacteroides fragilis Lipopolysaccharide and Inflammatory Signaling in Alzheimer’s Disease
Lukiw, W. J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01544 · Cited by 288
Grasset, E., Puel, A., Charpentier, J., Collet, X., Christensen, J. E., Tercé, F., & Burcelin, R. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.013 · Cited by 281
Hsieh, Y.-Y., Tung, S.-Y., Pan, H.-Y., Yen, C.-W., Xu, H.-W., Lin, Y.-J., Deng, Y.-F., Hsu, W.-T., Wu, C.-S., & Li, C. (2018) · Scientific Reports · doi:10.1038/s41598-017-18596-0 · Cited by 269
Alteration of the gut microbiota in Chinese population with chronic kidney disease
Jiang, S., Xie, S., Lv, D., Wang, P., He, H., Zhang, T., Zhou, Y., Lin, Q., Zhou, H., Jiang, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02989-2 · Cited by 266
Gut microbiota, inflammation and colorectal cancer
Sun, J., & Kato, I. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2016.03.004 · Cited by 257 · cited 1×
“The present study identified five previously reported genera in the phylum Bacteroidetes, including Porphyromonas , Prevotella , Paraprevotella and Flavobacterium (38,39).”
Methods to determine intestinal permeability and bacterial translocation during liver disease
Wang, L., Llorente, C., Hartmann, P., Yang, A.-M., Chen, P., & Schnabl, B. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.12.015 · Cited by 257
Discovery of new biosynthetic pathways: the lipid A story
Raetz, C. R. H., Guan, Z., Ingram, B. O., Six, D. A., Song, F., Wang, X., & Zhao, J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800060-jlr200 · Cited by 232
Diabetes, Hyperglycemia, and Inflammation in Older Individuals
de Rekeneire, N., Peila, R., Ding, J., Colbert, L. H., Visser, M., Shorr, R. I., Kritchevsky, S. B., Kuller, L. H., Strotmeyer, E. S., Schwartz, A. V., et al. (2006) · Diabetes Care · doi:10.2337/dc05-2327 · Cited by 230
Tidswell, M., Tillis, W., LaRosa, S. P., Lynn, M., Wittek, A. E., Kao, R., Wheeler, J., Gogate, J., & Opal, S. M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b07b78 · Cited by 229
Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease
Sabatino, A., Regolisti, G., Cosola, C., Gesualdo, L., & Fiaccadori, E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0841-z · Cited by 200
Al-Obaide, M., Singh, R., Datta, P., Rewers-Felkins, K., Salguero, M., Al-Obaidi, I., Kottapalli, K., & Vasylyeva, T. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6090086 · Cited by 194
Self-citationGut microbiome and kidney disease: a bidirectional relationship
Al Khodor, S., & Shatat, I. F. (2017) · Pediatric Nephrology · doi:10.1007/s00467-016-3392-7 · Cited by 191
Mafra, D., Lobo, J. C., Barros, A. F. H., Koppe, L., Vaziri, N. D., & Fouque, D. P. (2014) · Future Microbiology · doi:10.2217/fmb.13.165 · Cited by 167
Harsch, I. A., & Konturek, P. C. (2018) · Medical Sciences · doi:10.3390/medsci6020032 · Cited by 165
Carpenter, S., & O'Neill, L. A. J. (2009) · Biochemical Journal · doi:10.1042/bj20090616 · Cited by 164
Hiergeist, A., Reischl, U., & Gessner, A. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.03.005 · Cited by 158
The Immunobiology of Toll-Like Receptor 4 Agonists: From Endotoxin Tolerance to Immunoadjuvants
Bohannon, J. K., Hernandez, A., Enkhbaatar, P., Adams, W. L., & Sherwood, E. R. (2013) · Shock · doi:10.1097/shk.0000000000000042 · Cited by 154
Effects of Antidiabetic Drugs on Gut Microbiota Composition
Montandon, S., & Jornayvaz, F. (2017) · Genes · doi:10.3390/genes8100250 · Cited by 135
A comparison of phenotype definitions for diabetes mellitus
Richesson, R., Rusincovitch, S. A., Wixted, D., Batch, B. C., Feinglos, M. N., Miranda, M. L., Hammond, W. E., Califf, R. M., & Spratt, S. E. (2013) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-001952 · Cited by 126
Structure-Activity Relationships in Lipopolysaccharides of Bacteroides fragilis
Lindberg, A. A., Weintraub, A., Zähringer, U., & Rietschel, E. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.supplement_2.s133 · Cited by 113
Obesity and the gut microbiome: Striving for causality
Harley, I. T. W., & Karp, C. L. (2012) · Molecular Metabolism · doi:10.1016/j.molmet.2012.07.002 · Cited by 106
Wang, F., Liu, J., Weng, T., Shen, K., Chen, Z., Yu, Y., Huang, Q., Wang, G., Liu, Z., & Jin, S. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12515 · Cited by 89
Dietary patterns reflecting healthy food choices are associated with lower serum LPS activity
Ahola, A. J., Lassenius, M. I., Forsblom, C. M., Harjutsalo, V., Lehto, M. J., & Groop, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-06885-7 · Cited by 89
Li, C., Gao, M., Zhang, W., Chen, C., Zhou, F., Hu, Z., & Zeng, C. (2016) · Scientific Reports · doi:10.1038/srep29142 · Cited by 87
Small samples: does size matter?
Anderson, A. J., & Vingrys, A. J. (2001) · PubMed · Cited by 86
Fallucca, F., Porrata, C., Fallucca, S., & Pianesi, M. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2518 · Cited by 66
Leptotrichia Bacteremia in Patients Receiving High-Dose Chemotherapy
Couturier, M. R., Slechta, E. S., Goulston, C., Fisher, M. A., & Hanson, K. E. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05926-11 · Cited by 66
Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis
Chaves, L. D., McSkimming, D. I., Bryniarski, M. A., Honan, A. M., Abyad, S., Thomas, S. A., Wells, S., Buck, M. J., Sun, Y., Genco, R. J., et al. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00092.2018 · Cited by 62
Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity
Bu, J., & Wang, Z. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/6458094 · Cited by 60
Regulators of TLR4 Signaling by Endotoxins
McGettrick, A. F., & O'Neill, L. A. J. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-9078-2_7 · Cited by 53
Terawaki, H., Yokoyama, K., Yamada, Y., Maruyama, Y., Iida, R., Hanaoka, K., Yamamoto, H., Obata, T., & Hosoya, T. (2010) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2010.00815.x · Cited by 46
Cited by
High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review
Malesza, I. J., Malesza, M., Walkowiak, J., Mussin, N., Walkowiak, D., Aringazina, R., Bartkowiak-Wieczorek, J., & Mądry, E. (2021) · Cells · doi:10.3390/cells10113164 · Cited by 782
Gut Microbiota and Intestinal Trans-Epithelial Permeability
Allam-Ndoul, B., Castonguay-Paradis, S., & Veilleux, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176402 · Cited by 351
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus
Zhou, Z., Sun, B., Yu, D., & Zhu, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.834485 · Cited by 327
Sehnal, L., Brammer-Robbins, E., Wormington, A. M., Blaha, L., Bisesi, J., Larkin, I., Martyniuk, C. J., Simonin, M., & Adamovsky, O. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.567408 · Cited by 305
Metadata
- Authors
- Salguero, M., Al‑Obaide, M., Singh, R., Siepmann, T., & Vasylyeva, T.
- Venue
- Experimental and Therapeutic Medicine
- Publisher
- Spandidos Publications
- Published
- 2019-08-26
- Volume
- 18
- Issue
- 5
- Pages
- 3461-3469
- ISSN
- 1792-0981 (ISSN-L)
- 1792-1015
- OpenAlex
- W2970043613
- Cited by
- 257
- References
- 63
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.